Free tool
Stocks listed on XETRA
We cover 47 companies listed on XETRA. The median market value in the group is $316.56M. Across the group, the median move over the past trading day is +0.77%. 51% of the 45 with a 200-day average trade above it. Price change over the past year runs from −45.7% to +74.5% across the middle 80 percent of the group, with a median of −3.1%.
Other lists in this group
Table
47 of 1,273 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| RHO.DE | Roche Holding AG | 405.40 EUR | +2.01% | +14.00% | +41.42% |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.82% | −12.36% | −44.50% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | 82.40 EUR | +8.42% | +52.87% | +53.42% |
| RDC.DE | Redcare Pharmacy NV | 62.05 EUR | −10.46% | −6.06% | −23.82% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | 14.70 EUR | +13.08% | +15.81% | +24.49% |
| GXI.DE | Gerresheimer AG | 25.58 EUR | −9.23% | −7.99% | −39.73% |
| EUZ.DE | Eckert & Ziegler SE | 13.18 EUR | −4.56% | −12.19% | −24.60% |
| EVT.DE | Evotec SE | 3.25 EUR | −6.22% | −41.07% | −45.75% |
| 2HQ0.DE | Tilray Brands, Inc. | 4.07 EUR | +21.13% | −48.80% | −67.56% |
| AYJ.DE | Valneva SE | 2.98 EUR | +35.29% | −23.93% | −21.89% |
| FYB.DE | Formycon AG | 18.44 EUR | −2.64% | −29.35% | −25.04% |
| M12.DE | M1 Kliniken AG | 18.36 EUR | −2.86% | +1.10% | +37.84% |
| ILM1.DE | Medios AG | 10.92 EUR | −1.62% | −25.61% | −26.32% |
| SBS.DE | Stratec SE | 22.85 EUR | +11.46% | +3.39% | −16.91% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | 13.50 EUR | +8.87% | −48.77% | +47.70% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.45 EUR | +31.64% | +51.39% | +75.81% |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% |
| LIK.DE | LIMES Schlosskliniken AG | 570.00 EUR | −0.87% | +58.33% | +70.66% |
| VME.DE | Viromed Medical AG | 6.50 EUR | −15.03% | +71.96% | +85.71% |
| HPHA.DE | Heidelberg Pharma AG | 2.52 EUR | −2.70% | +0.80% | −31.15% |
| 88Q.DE | 4basebio PLC | 5.35 EUR | −3.60% | −20.15% | −45.69% |
| 7V0.DE | Novogenia AG | 6.40 EUR | +7.56% | −16.34% | −25.00% |
| HIGH.DE | Cantourage Group SE | 6.00 EUR | +5.63% | +80.72% | +51.90% |
| AJ91.DE | DocCheck AG | 10.90 EUR | −6.03% | −13.49% | −9.92% |
| V3V.DE | FamiCord AG | 2.86 EUR | +0.70% | −52.73% | −61.35% |
| M3V.DE | MeVis Medical Solutions AG | 23.80 EUR | +2.59% | +0.39% | −0.42% |
| BXT.DE | BioNxt Solutions Inc. | 0.22 EUR | +5.26% | −48.72% | −65.52% |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% |
| NN6.DE | NanoRepro AG | 1.85 EUR | −5.38% | +19.81% | −4.90% |
| AAQ1.DE | aap Implantate AG | 1.46 EUR | −7.01% | +6.57% | −15.12% |
| MAK.DE | Maternus-Kliniken Aktiengesellschaft | 0.92 EUR | −3.16% | −6.60% | −22.03% |
| B8FK.DE | Biofrontera AG | 2.53 EUR | −0.78% | −0.78% | −3.07% |
| GME.DE | Geratherm Medical AG | 2.58 EUR | +1.18% | −10.42% | −16.50% |
| SBX.DE | SynBiotic SE | 0.74 EUR | −32.10% | −71.02% | −76.63% |
| 27N0.DE | Cannovum Cannabis AG | 0.56 EUR | +10.76% | +24.94% | +22.47% |
| BIG1.DE | Bio-Gate AG | 2.83 EUR | −14.39% | +262.18% | +200.53% |
| PTP.DE | Pentixapharm Holding AG | 1.85 EUR | −5.61% | +20.13% | +5.47% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.